169352 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Sub-classes:QUANTITATION OF TAMOXIFEN AND METABOLITES THEREOF BY MASS SPECTROMETRY
#2BINDING AGENT RECOGNITION OF DRUG-PEPTIDE CONJUGATES
#3HIGH DYNAMIC RANGE ASSAYS IN HAZARDOUS CONTAMINANT TESTING
#4Method of Determining Risk for Chronic Stress and Stroke
#5Rapid Method of Forensic Toxicology in Post-Mortem Individuals Using Muscle Tissue Testing
#6COMPOSITIONS AND METHODS FOR LABELING AND DETECTING BINDING PARTNERS
#7CELL-BASED ASSAY FOR QUANTIFYING THE POTENCY AND EFFICACY OF CANNABINOIDS AND/OR TERPENOIDS, AND METHODS OF USE THEREOF
#8DETECTION OF ANALYTES BY PROTEIN SWITCHES
#9AMIDE-BASED MOLECULAR CAGES FOR THE HIGHLY SELECTIVE AND SENSITIVE DETECTION OF NICOTINE
#10MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#11MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#12NEUTRALIZATION ANTIBODY ASSAY METHOD
#13APPARATUS AND METHOD
#14ANTI-NALOXONE AND ANTI-NALTREXONE MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF
#15A SEMI-AUTOMATIC SEGMENTATION SYSTEM FOR PARTICLE MEASUREMENTS FROM MICROSCOPY IMAGES
#16INSPECTION APPARATUS
#17WEE1 COMPOUND FOR TREATING UTERINE SEROUS CARCINOMA
#18METHODS FOR ANALYZING DRUG MOLECULES IN MAMMALIAN TISSUES
#19MASS SPECTROMETRIC QUANTITATION ASSAY FOR METABOLITES OF LEFLUNOMIDE
#20METHODS FOR LABELING URINE IN A SUBJECT WITH FLUOROPHORES
#21METHOD OF INHIBITING TAU PHOSPHORYLATION
#22LOW RESIDUE SAMPLING MATERIAL FOR SMALL MOLECULE DRUG DETECTION AND USE OF THE SAME
#23UTILIZING TRACE AMOUNTS OF A SUSPECTED TARGET MOLECULE AS A CATALYST IN DETECTION REACTIONS
#24METHOD OF INHIBITING TAU PHOSPHORYLATION
#25DATE RAPE DRUG DETECTION DEVICE AND METHOD OF USING SAME
#26STABILITY-ENHANCING COMPOSITIONS AND METHODS OF PREPARING COMPOUNDS
#27DATE RAPE DRUG DETECTION DEVICE AND METHOD OF USING SAME
#28DATE RAPE DRUG DETECTION DEVICE AND METHOD OF USING SAME
#29DATE RAPE DRUG DETECTION DEVICE AND METHOD OF USING SAME
#30DATE RAPE DRUG DETECTION DEVICE AND METHOD OF USING SAME
#31DETECTING THE PRESENCE OF URINARY STONE DISEASE USING A PLURALITY OF URINARY METABOLITES
#32OPTICAL READER FOR ANALYTE TESTING
#33MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#34HAZARDOUS CONTAMINANT COLLECTION DEVICE WITH INTEGRATED SWAB AND TEST DEVICE
#35MOLECULAR IDENTIFICATION OF COMPOUNDS TARGETING TRISTETRAPROLIN (TTP) AND TTP PHOSPHORYLATION
#36Methods and Devices for Detection of THC
#37ANTIBODY AND ANTIGEN BINDING FRAGMENTS THEREOF
#38METHODS FOR MITIGATING DRUG TARGET INTERFERENCE IN AN ANTI-DRUG ANTIBODY (ADA) IMMUNOASSAY
#39Chronic Disease Management Test to Inform Clinical Care of Patients with Chronic Conditions
#40Compositions and Methods for Detecting Analytes in Oral Fluids
#41MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#42METHOD FOR DETECTING DRUG ANTIBODY IN SPECIMEN
#43MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#44METHOD FOR DIAGNOSING AND TREATING IRRITABLE BOWEL SYNDROME
#45OPIOID DETECTION KIT AND METHOD THEREOF
#46CELL-BASED ASSAY FOR QUANTIFYING THE POTENCY AND EFFICACY OF CANNABINOIDS AND/OR TERPENOIDS, AND METHODS OF USE THEREOF
#47ASSAYS FOR DETECTING THE PRESENCE OR AMOUNT OF AN ANTI-DRUG ANTIBODY
#48FLUID SPECIMEN TESTING
#49AEROSOL-GENERATING ARTICLE WITH BIOMARKER SENSOR
#50ENZYME-CONJUGATED MAGNETIC BEADS SUSPENDED IN INTERNAL STANDARD BUFFER
#51INDIRECT HOMOGENEOUS MOBILITY SHIFT ASSAYS FOR THE DETECTION OF BIOLOGICS IN PATIENT SAMPLES
#52BIOLOGICAL SAMPLE PREPARATION AND ANALYSIS
#53METHOD FOR MEASURING RELATIVE fu RATIO BY DYNAMIC ANALYSIS
#54Mass spectrometric quantitation assay for metabolites of leflunomide
#55METHOD OF INHIBITING TAU PHOSPHORYLATION
#56AIR GAP PAPER ANALYTICAL DEVICE AND FABRICATION
#57Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor
#58Quantitation of tamoxifen and metabolites thereof by mass spectrometry
#59METHODS FOR LABELING URINE IN A SUBJECT WITH FLUOROPHORES
#60MODULAR KINETICALLY-CONTROLLED FUNCTIONAL RNA CONSTRUCTS AND RELATED COMPOSITIONS, SYSTEMS, AND METHODS
#61LOCK AND KEY TEMPLATION OF MOLECULARLY IMPRINTED POLYMER FOR SMALL MOLECULE RECOGNITION
#62RECOGNITION OF CELLULAR TARGET BINDING BY A BIOACTIVE AGENT USING INTRACELLULAR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER
#63COMPOSITIONS, KITS AND METHODS FOR COLLECTING ANALYTE IN A SALIVA SAMPLE
#64SAMPLE COLLECTOR
#65MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#66REAGENT COMPOSITION FOR DETECTING ILLICIT DRUGS AND SHEET KIT FOR DETECTING ILLICIT DRUGS COMPRISING SAME
#67VIRION OSCILLATOR MICROARRAYS, METHODS, AND RELATED ASPECTS FOR DETERMINING BINDING KINETICS OF LIGANDS
#68METHODS FOR PREDICTION, DETECTION AND MONITORING OF SUBSTANCEUSE DISORDERS AND/OR AN INFECTION
#69Method for Determining Medication Adherence and Taggants Therefo
#70CYCLOPHOSPHAMIDE ANALOGS FOR USE AS IMMUNOGENS AND ASSAY CONJUGATES FOR AN IMMUNOASSAY OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE
#71SYSTEMS FOR DETECTION
#72PROTEIN DIAGNOSTIC BIOMARKER FOR SEVERE DRUG ERUPTION
#73Quantitation of tamoxifen and metabolites thereof by mass spectrometry
#74ASSAYS TO QUANTITATE DRUG AND TARGET CONCENTRATIONS
#75METHODS FOR PREDICTION OF ANTI-TNF ALPHA DRUG LEVELS AND AUTOANTIBODY FORMATION
#76Detection kit and method for detecting abused drugs
#77DEVICE FOR RAPID AND QUANTITATIVE DETECTION OF DRUGS OF ABUSE IN SWEAT
#78DOUBLE-DIGESTION ASSAY FOR ANALYZING LIGAND-DRUG CONJUGATES
#79MARKERS FOR PHARMACEUTICALS
#80SYSTEMS FOR DETECTION
#81METHODS FOR LABELING URINE IN A SUBJECT WITH FLUOROPHORES
#82Mass spectrometry methods and related materials
#83SEQUENCING METHOD, SYSTEM AND KIT OF LOW MOLECULAR WEIGHT HEPARIN OLIGOSACCHARIDES
#84Method for detecting methimazole
#85Methimazole adsorbant sample slide
#86METHODS FOR ANALYZING AND AUTHENTICATING A SAMPLE FROM A SUBJECT
#87Compositions for Determining Vaccine Potency
#88DETECTION OF ANALYTES BY PROTEIN SWITCHES
#89ANTIBODY DIRECTED AGAINST TENOFOVIR AND DERIVATIVES THEREOF
#90DETECTION OF NICOTINE, CANNABINOIDS AND DRUGS OF ABUSE ON VAPING DEVICE SURFACES AND VAPING LIQUID FORMULATIONS
#91ANTI-VLA-4 RELATED ASSAYS
#92HIGH DYNAMIC RANGE ASSAYS IN HAZARDOUS CONTAMINANT TESTING
#93Methods and kits for the derivatization of a biogenic amine
#94Use of low-bind surface coatings for analysis of tyrosine kinase inhibitors
#95MOLECULAR CRYPTOGRAPHIC SAMPLING DEVICES AND METHODS OF MAKING AND USING
#96Optical reader for analyte testing
#97Modular point-of-care devices, systems, and uses thereof
#98Method of Determining Risk for Chronic Stress and Stroke
#99Mass spectrometric quantitation assay for metabolites of leflunomide
#100COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS
#101Compositions and methods for the detection of host cell proteins
#102EVALUATING METHOD FOR PHARMACOLOGICAL ACTIONS OF IMMUNE CHECKPOINT INHIBITORS, CALCULATING METHOD, EVALUATING APPARATUS, CALCULATING APPARATUS, EVALUATING PROGRAM, CALCULATING PROGRAM, RECORDING MEDIUM, EVALUATING SYSTEM, AND TERMINAL APPARATUS
#103METHODS FOR USING MASS SPECTROSCOPY IN MULTIPLEX TARGET EVALUATIONS
#104ANALYTE DETECTION IMMUNOASSAY
#105METABOLITES OF BICTEGRAVIR
#106APPARATUS FOR DETECTING ANALYTE IN A LIQUID SAMPLE AND METHOD THEREOF
#107ELUTION OF MICROPARTICLES BY SIZE EXCLUSION CHROMATOGRAPHY USING WATER AS A MOBILE PHASE
#108Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof
#109NOVEL LIGAND ASSAYS
#110Hazardous contaminant collection device with integrated swab and test device
#111Device and a method for measurements by Raman spectroscopy
#112Assays for detecting the presence or amount of an anti-drug antibody
#113Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200
#114SYSTEM AND METHOD FOR DETECTING THERAPEUTIC AGENTS TO MONITOR ADHERENCE TO A TREATMENT REGIMEN
#115COMPOSITIONS AND COMPOUNDS FOR BIOANALYSIS
#116METHOD AND DEVICE FOR DETECTING COAGULATION FACTOR INHIBITORS AND ANTIPLATELETS IN A SAMPLE
#117Method of quantifying lysergic acid diethylamide (LSD) and 2,3-dihydro-3-hydroxy-2-oxo lysergide (O-H-LSD) in human plasma
#118Desmoglein 2 (DSG2) binding proteins and uses therefor
#119ASSAY DEVICE
#120METHODS OF MONITORING SAFETY OF QUERCETIN COMPOSITIONS
#121Multidimensional chromatography method for analysis of antibody-drug conjugates
#122APTAMER AGAINST IRINOTECAN
#123ANTI-NALOXONE AND ANTI-NALTREXONE MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF
#124LIVING BODY INFORMATION ACQUISITION SYSTEM, HEALTH MANAGEMENT SERVER, AND SYSTEM
#125Molecularly-imprinted-polymer coated conductive nanoparticles for cotinine detection, and associated devices and methods
#126Fluid test device and module
#127Slope spectroscopy standards
#128Alzheimer's Disease Assay in a Living Patient
#129METHODS FOR DETECTING AND/OR MEASURING ANTI-DRUG ANTIBODIES, IN PARTICULAR TREATMENT-EMERGENT ANTI-DRUG ANTIBODIES
#130Systems and Methods for Pesticide Detection
#131MULTISIGNAL REAGENTS FOR LABELING ANALYTES
#132METHODS AND DEVICES THAT CHANGE COLOR TO INDICATE THE PRESENCE OF OPIOIDS AND OTHER NARCOTICS
#133Method and apparatus for testing near infrared-photoimmunotherapy treatment
#134DEVICE AND METHOD FOR DISTINGUISHING SMOKING E-CIGARETTE FROM SMOKING CIGARETTE
#135METHODS FOR MEASURING AND STABILIZING STAT3 INHIBITORS
#136PENTOSAN POLYSULFATE SODIUM FOR THE TREATMENT OF SICKLE CELL DISEASE
#137DIRECT READING DETECTION KITS FOR SURFACE CONTAMINATION BY ANTINEOPLASTIC DRUGS
#138METHODS FOR IMPROVING PURITY OF TENOFOVIR DISOPROXIL FUMARATE, AND COMPOSITIONS THEREOF
#139PROTEIN RECOGNIZING DRUG MOIETY OF ANTIBODY-DRUG CONJUGATE
#140OPTIMIZATION AND INDIVIDUALIZATION OF MEDICATION SELECTION AND DOSING
#141MODULAR POINT-OF-CARE DEVICES, SYSTEMS, AND USES THEREOF
#142COLLAGEN IV BINDING ASSAY FOR THE DETECTION OF COLLAGEN VII
#143MULTIPLEXED TOTAL ANTIBODY AND ANTIBODY-CONJUGATED DRUG QUANTIFICATION ASSAY
#144Method, Pretreatment Reagent and Kit for Detecting Drug in Hair
#145METHODS FOR CHARACTERIZING HOST-CELL PROTEINS
#146Method of inhibiting tau phosphorylation
#147METHODS FOR IMPROVING PURITY OF TENOFOVIR DISOPROXIL FUMARATE, AND COMPOSITIONS THEREOF
#148Analyte Detection method
#149METHODS FOR LABELING URINE IN A SUBJECT WITH FLUOROPHORES
#150Human Neural Organoid Platform for Detecting Drugs of Abuse Disorder Susceptibility and Therapeutic Countermeasure and Non-Addictive Pain Medication Development
#151Rapid Method of Forensic Toxicology in Post-Mortem Individuals Using Muscle Tissue Testing
#152Slope spectroscopy standards
#153Quantitation of tamoxifen and metabolites thereof by mass spectrometry
#154All-in-one handheld machine for testing drugs in hairs
#155ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF
#156LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF ANTIBODIES AGAINST BIOLOGICAL DRUGS
#157METHOD AND APPARATUS FOR ANALYSING SKIN-PRINTS
#158SYSTEMS AND METHODS FOR CHARACTERIZING SURFACTANT PROTEIN D (SP-D) OLIGOMERS
#159A METHOD OF ANALYSING A SKIN-PRINT
#160Method for rapid and quantitative determination of sildenafil in cocktail
#161Compound and dimer complex embodiments for supramolecular sensing
#162ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF
#163EZETIMIBE METABOLITE AS A NON-INVASIVE BIOMARKER FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#164Nontoxic compounds for use as taggants in nutritional and pharmaceutical products
#165Fluid specimen testing
#166MULTIPIN SOLID PHASE MICROEXTRACTION DEVICE
#167Maribavir isomers, compositions, methods of making and methods of using
#168Novel method of treating dystonia
#169Cathinone test
#170Thin-layer chromatography system and method for assessing analyte concentrations in samples
#171METHODS OF DIAGNOSIS AND TREATMENT OF LIVER DISEASES USING OBETICHOLIC ACID
#172Detecting an analyte in the presence of an interferent
#173METHOD FOR ADAPTING DOSES OF COMBINATION THERAPIES
#174Methods and devices for detection of THC
#175Clozapine Immunoassay
#176Desmoglein 2 (DSG2) binding proteins and uses therefor
#177Cell-based assay for quantifying the potency and efficacy of cannabinoids and/or terpenoids, and methods of use thereof
#178Optimizing mifepristone levels for Cushing's patients
#179Hazardous contaminant collection device with integrated swab and test device
#180Detection kit and method for detecting abused drugs
#181Mass spectrometric quantitation assay for metabolites of leflunomide
#182SOLID STATE ELECTRODES, METHODS OF MAKING, AND METHODS OF USE IN SENSING
#183METHODS FOR IMPROVING PURITY OF TENOFOVIR DISOPROXIL FUMARATE, AND COMPOSITIONS THEREOF
#184Quantitative detection method of rare earth doped calcium phosphate fluorescent nanoparticles in organisms
#185Methods of monitoring safety of quercetin compositions
#186SYSTEM AND METHOD FOR DETECTING THERAPEUTIC AGENTS TO MONITOR ADHERENCE TO A TREATMENT REGIMEN
#187MARKERS FOR PHARMACEUTICALS
#188Mutant human estrogen receptor-α and methods of use thereof
#189Methods for prediction of anti-TNF α drug levels and autoantibody formation
#190Diagnostic test for distinguishing the smoking status of a subject
#1915-ALA for detection of brain tumors
#192Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#193Anti-VLA-4 related assays
#194Method for rapid identification of pharmacologically active chemical entities associated with the efficacy of ethnobotanical substances
#195Method of using an electronic chemically sensitive resistor array for the differentiation of synthetic and authentic urine specimens
#196IR Probe for Detection of Contaminants in Sealed Containers
#197Maribavir isomers, compositions, methods of making and methods of using
#198Toll-like receptor 9 antagonists
#199ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF
#200Hybridoma cell line of secreting meloxicam monoclonal antibodies and application thereof
#201Antibodies to risperidone and use thereof
#202Methods for mitigating drug target interference in an anti-drug antibody (ADA) immunoassay
#203Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide
#204Slope spectroscopy standards
#205Targeted protein characterization by mass spectrometry
#206CELL-PENETRATING FLUORESCENT DYES WITH SECONDARY ALCOHOL FUNCTIONALITIES
#207Methods for determining vaccine potency
#208Antibodies to paliperidone haptens and use thereof
#209Antibodies to aripiprazole haptens and use thereof
#210Methods for detecting antibodies
#211Antibodies to olanzapine and use thereof
#212Strip for measuring blood lipids
#213INTEGRATED DEVICE FOR LUNG HEALTH ASSESSMENT
#214Multidimensional chromatography method for analysis of antibody-drug conjugates
#215Calibration systems and methods for analyte detectors
#216Disease biomarkers and treatment methods related thereto
#217ANTIBODIES TO QUETIAPINE AND USE THEREOF
#218Alzheimer's disease assay in a living patient
#219Rapid and sensitive method of forensic toxicology in post-mortem subjects and in live and post-mortem animals using oral fluid testing
#220Optimizing Successful Outcomes for Repurposing Existing Pharmaceutical Compounds
#221Leveraging genomic, phenotypic and pharmacological data to cure disease
#222Methods for identifying proteins that bind ligands
#223Systems and methods for pesticide detection using mass spectroscopy
#224Metabolites of bictegravir
#225Personalized healthcare P4 cardiac health and wellness monitoring system and method utilizing TMAO and troponin
#226Quantitation of Tamoxifen and metabolites thereof by mass spectrometry
#227Oral and saliva based equine ID drug monitoring system
#228Piericidin bacterial inhibitors
#229Optical reader for analyte testing
#230BIOMOLECULAR INTERACTION DETECTION DEVICES AND METHODS
#231Methods and kits for the derivatization of a biogenic amine
#232Compositions and methods for blood storage
#233SYSTEMS AND METHODS FOR EVALUATING INTERSTITIAL FLUIDS
#234Multisignal reagents for labeling analytes
#235Antibodies to aripiprazole and use thereof
#236Compositions and methods for the detection of host cell proteins
#237Molecularly-imprinted-polymer coated conductive nanoparticles for cotinine detection, and associated devices and methods
#238Optimizing mifepristone levels for cushing's patients
#239NEW TOLL-LIKE RECEPTOR 9 ANTAGONISTS
#240Real-time and Continuous Measurement in Vivo Using Aptamer-Based Biosensors
#241Desmoglein 2 (DSG2) binding proteins and uses therefor
#242High dynamic range assays in hazardous contaminant testing
#243Universal method to capture and analyze ADCs for characterization of drug distribution and the drug-to-antibody ratio in biological samples
#244Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
#245FORMULATIONS AND SCREENING OF BIOLOGICAL THERAPEUTIC AGENTS
#246Methods and dose packs for monitoring medication adherence
#247METHODS AND COMPOSITIONS FOR USING SOLVATOCHROMIC DYES TO DETECT THE PRESENCE OF HOMEOPATHIC POTENCIES
#248Integrated device for analyte testing, confirmation, and donor identity verification
#249OMA1 activity assay
#250SYSTEM AND METHOD FOR DETECTING THERAPEUTIC AGENTS TO MONITOR ADHERENCE TO A TREATMENT REGIMEN
#251Tenofovir detection assay
#252METHOD FOR DETECTING AN ANALYTE
#253METHOD FOR PREDICTING THE BIOAVAILABILITY OF A RADIOELEMENT FOLLOWING CONTAMINATION, AND USES THEREOF
#254Three-step acid dissociation enzyme linked immunosorbent (TADELIS) assay
#255Method for designing compounds and compositions useful for targeting high stoichiometric complexes to treat conditions, including treatment of viruses, bacteria, and cancers having acquired drug resistance
#256IMiD screening methods IMiD-sensitive cells with mutant CRBN
#257Tags for Identifying and Tracking Pharmaceutical and Nutritional Products using Paramagnetic Microparticles and Detectable Chemicals
#258METHOD AND DEVICE FOR MONITORING MEDICATION USAGE
#259Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide
#260PENTOSAN POLYSULFATE SODIUM FOR THE TREATMENT OF SICKLE CELL DISEASE
#261WEARABLE APPARATUS FOR DETECTING A TARGET SUBSTANCE IN A LIQUID
#262Method of detecting drug taggants in biological samples to assess drug decay
#263Method of determining consumption of decayed drug through drug taggants
#264Identification of consumed drugs and food by unique near infrared tag libraries
#265Method of measuring artificial sweeteners in bodily waste to identify and quantify drug consumption
#266Methods for labeling urine in a subject with fluorophores
#267Drug tracking system including food dyes detectable in bodily waste
#268BIOMETRIC CONFIRMATION OF SAMPLE INTEGRITY
#269METHODS FOR BIOANALYSIS OF 6-DIAZO-5-OXO-L-NORLEUCINE (DON) AND OTHER GLUTAMINE ANTAGONISTS
#270Method for detecting methimazole by surface-enhanced raman scattering
#271Drug detection device
#272Microfluidic Platform For Rapid Biologics Analysis
#273Modular point-of-care devices, systems, and uses thereof
#274Modular point-of-care devices, systems, and uses thereof
#275MECHANISM AND DRUG TARGETS FOR REDUCING CELL EDEMA (NEUROPROTECTION) AND CYTOPLASMIC EXCITABILITY IN ASTROCYTES IN NORMAL AND PATHOLOGICAL STATES
#276Analyte detection immunoassay
#277VERSATILE AND SENSITIVE BIOSENSOR
#278Immunoassay for phenethylamines of the 2C and DO sub-families
#279Optimizing mifepristone levels for Cushing's patients
#280Method for proposal of compound analog structures using accurate product ion spectra
#281Red blood cell dynamics for gastrointestinal evaluation
#282Rapid and sensitive method of forensic toxicology in post-mortem subjects using oral fluid testing
#283Method and apparatus for the analysis of compounds
#284SYSTEMS AND METHODS FOR DISTINGUISHING COTININE FROM ANABASINE IN A POINT-OF-CARE TESTING DEVICE
#285Toilet apparatus for detecting fluorescent drug markers in urine
#286Composition and methods for extracting mycotoxins
#287Antibodies to aripiprazole haptens and use thereof
#288METHOD FOR QUANTIFYING MONOCLONAL ANTIBODY
#289Anti-VLA-4 related assays
#290METHODS, DEVICES, AND REAGENTS FOR MONITORING PACLITAXEL CONCENTRATION IN PLASMA FOR PHARMACOKINETIC-GUIDED DOSING OF PACLITAXEL
#291Reagents and methods of use with automated analyzers for obtaining a specific gravity index for urine
#292SAMPLE COLLECTION, MANAGEMENT, AND EVALUATION
#293Antibodies to quetiapine haptens and use thereof
#294Assays for detecting the presence or amount of an anti-drug antibody
#295Materials and methods for the detection of trace amounts of substances in biological and environmental samples
#296NORMALIZING MEASURED DRUG CONCENTRATIONS IN ORAL FLUIDS AND TESTING FOR POTENTIAL NON-COMPLIANCE WITH DRUG TREATMENT REGIMEN
#297Mass spectrometric quantitation assay for metabolites of leflunomide
#298VITRO RELEASE ASSAY FOR LIPOSOME ENCAPSULATED VINCRISTINE
#299Urinal cartridge and urinal having the same
#300Antibodies to risperidone haptens and use thereof